BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33326597)

  • 21. Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.
    Clark KEN; Nevin WD; Mahungu T; Lachmann H; Singh A
    Clin Infect Dis; 2021 Nov; 73(9):e3110-e3112. PubMed ID: 32985664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.
    Alhumaidan W; Al-Otaibi A; Elyamany G; Alabbas F; Ali TB
    Pediatr Hematol Oncol; 2021 May; 38(4):406-409. PubMed ID: 33635161
    [No Abstract]   [Full Text] [Related]  

  • 23. Neonatal COVID and Familial Hemophagocytic Lymphohistiocytosis.
    Hon KLE; Leung KKY; Hui WF; Cheung WL; Leung WH
    Pediatr Emerg Care; 2022 Mar; 38(3):e1094-e1096. PubMed ID: 35226638
    [No Abstract]   [Full Text] [Related]  

  • 24. Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination.
    Attwell L; Zaw T; McCormick J; Marks J; McCarthy H
    J Clin Pathol; 2022 Apr; 75(4):282-284. PubMed ID: 34301797
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.
    Obuchowska A; Standyło A; Obuchowska K; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does your unwell patient have haemophagocytic lymphohistiocytosis?
    Holloway A; Ahmed S; Manson JJ
    Br J Hosp Med (Lond); 2024 Mar; 85(3):1-12. PubMed ID: 38557089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaucher Disease Type 2 Manifested as Hemophagocytic Lymphohistiocytosis in a Neonate in the COVID-19 Era.
    Kosmeri C; Rallis D; Baltogianni M; Bouza H; Lykopoulou L; Lianou L; Papadopoulou E; Tzanoudaki M; Farmaki E; Papadakis V; Giapros V; Makis A
    J Pediatr Hematol Oncol; 2023 May; 45(4):e506-e509. PubMed ID: 36162002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain damage resembling acute necrotizing encephalopathy as a specific manifestation of haemophagocytic lymphohistiocytosis - induced by hypersensitivity.
    Dai D; Wen F; Liu S; Zhou S
    Ital J Pediatr; 2016 Aug; 42(1):79. PubMed ID: 27576518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined IL-6 and JAK/STAT inhibition therapy in COVID-19-related sHLH, potential game changer.
    Portsmore S; Tran Nguyen TN; Beacham E; Neelakantan P
    Br J Haematol; 2020 Aug; 190(4):525-528. PubMed ID: 32584421
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemophagocytic lymphohistiocytosis: an uncommon clinical presentation of tuberculosis.
    Shea YF; Chan JF; Kwok WC; Hwang YY; Chan TC; Ni MY; Li IW; Chiu PK; Luk JK; Chu LW
    Hong Kong Med J; 2012 Dec; 18(6):517-25. PubMed ID: 23223654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemophagocytic lymphohistiocytosis secondary to presumed congenital tuberculosis in a neonate.
    Kaur N; Britton PN; Isaacs D; Ging J; Campbell DE
    J Paediatr Child Health; 2019 Aug; 55(8):988-992. PubMed ID: 30779259
    [No Abstract]   [Full Text] [Related]  

  • 32. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
    Opoka-Winiarska V; Grywalska E; Roliński J
    BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
    Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
    J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset COVID-19-induced Hemophagocytic Syndrome.
    Kanematsu E; Nunokawa T; Chinen N; Komatsu A
    Intern Med; 2021 Nov; 60(21):3511. PubMed ID: 34433715
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.
    Dewaele K; Claeys R
    Blood; 2020 Jun; 135(25):2323. PubMed ID: 32556137
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination.
    Mungmunpuntipantip R; Wiwanitkit V
    Infection; 2022 Dec; 50(6):1615. PubMed ID: 35349078
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
    Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophagocytosis in bone marrow aspirates in patients with COVID-19.
    Debliquis A; Harzallah I; Mootien JY; Poidevin A; Labro G; Mejri A; Lamarque M; Kuteifan K; Drénou B
    Br J Haematol; 2020 Jul; 190(2):e70-e73. PubMed ID: 32529634
    [No Abstract]   [Full Text] [Related]  

  • 39. Histiocytosis-lymphadenopathy plus syndrome revealed by repeated secondary hemophagocytic lymphohistiocytosis.
    Singh A; Kumari A; Dabas A; Yadav S
    Pediatr Allergy Immunol; 2022 May; 33(5):e13787. PubMed ID: 35616891
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic.
    Sakamoto K; Ono R; Doi T; Koga Y; Shioda Y;
    Int J Hematol; 2022 Mar; 115(3):446-448. PubMed ID: 35113348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.